Skip to main content

Table 6 Summary of efficacy assessment scores

From: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Test

Baseline

1 month

1 year

EDSS mean scores

5.2

4.8*

4.5*

SNRS bladder/bowel/sexual dysfunction score (normal = 0)

− 4.7

− 2.7*

− 3.1

Nine Hole Peg Test—non-dominant hand average scores

35.1

30.2*

34.1

25-foot walk (second trial) times

17.5

11.5*

13.3

RAND SF-36 average scale

53.5

68.3***

63.5

  1. * p < 0.05 when compared to baseline; *** p < 0.001 when compared to baseline